Rapamune (sirolimus) is an immunosuppressant medicine used to prevent rejection of transplanted kidneys. Unlike tacrolimus and ciclosporin (which are calcineurin inhibitors), sirolimus works by blocking a different pathway (mTOR signalling) that immune cells use to divide and proliferate.
Sirolimus is often used in combination with calcineurin inhibitors or as a substitute for them in long-term maintenance therapy to reduce calcineurin inhibitor-related kidney toxicity.
Back To Top
Take Rapamune once daily, consistently at the same time. It can be taken with or without food, but always take it the same way (either with food or without) to ensure consistent absorption.
Do not eat grapefruit or drink grapefruit juice while taking Rapamune, as it significantly increases sirolimus levels.
For the oral solution, use the provided oral syringe to measure the dose. Mix with water or orange juice (at least 60 mL), stir well, and drink immediately. Do not use grapefruit juice or other juices.
Blood levels are measured regularly and the dose is adjusted to maintain a target trough concentration.
Back To Top
Take the missed dose as soon as you remember. If it is nearly time for the next dose, skip and continue your schedule. Contact your transplant team if you miss multiple doses.
Back To Top
Seek urgent medical attention. Sirolimus toxicity can cause severe immunosuppression, anaemia, and other serious effects.
Back To Top
Very common side effects:
Common side effects:
Serious side effects:
Regular blood tests for levels, blood count, kidney function, liver function, and lipids are required.
Back To Top
Sirolimus is metabolised by CYP3A4 and is a P-glycoprotein substrate. Key interactions include:
Tell your transplant team and pharmacist before starting any new medicine.
Back To Top
How does Rapamune differ from tacrolimus and ciclosporin?
Tacrolimus and ciclosporin are calcineurin inhibitors that suppress T-cells by blocking calcineurin. Sirolimus (Rapamune) targets a completely different pathway called mTOR, which controls cell division and proliferation. This different mechanism means it has a different toxicity profile: it does not cause the kidney toxicity associated with calcineurin inhibitors, but it does raise lipid levels and impairs wound healing. It is sometimes used as a calcineurin inhibitor-sparing strategy in patients whose kidneys are suffering from long-term tacrolimus or ciclosporin toxicity.
Why must I stop Rapamune before surgery?
Sirolimus blocks mTOR signalling, which is essential not only for immune cell division but also for wound healing processes. Taking sirolimus around the time of surgery significantly increases the risk of wound complications, including dehiscence (wound opening) and infection. Your transplant surgeon and team will plan when to stop and restart sirolimus around any planned procedures.
Back To Top
Ace provides accurate and independent information medically reviewed on prescription medications. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Back To Top